As of 2026-09-25, the Relative Valuation of Viracta Therapeutics Inc (VIRX) is (224.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Viracta Therapeutics Inc based on Relative Valuation is -288971.0%.
The range of the Relative Valuation is (216.75) - (217.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.1x - 30.1x | 27.6x |
| Forward P/E multiples | 23.7x - 25.2x | 24.4x |
| Fair Price | (216.75) - (217.62) | (224.74) |
| Upside | -278703.8% - -279813.7% | -288971.0% |
| Date | P/E |